Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications

Completed · Phase 4 · Has a placebo group

Conditions studied: Type 2 Diabetes Mellitus

In brief

The purpose of this study is to determine whether saxagliptin can reduce the risk of cardiovascular events when used alone or added to other diabetes medications

Key facts

Study ID

NCT01107886

Run by

AstraZeneca

People needed

18206

Starts

2010-05-01

Expected to finish

2013-05-01

Last updated by the study team

2014-07-17

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with type 2 diabetes mellitus
• HbA1c ≥6.5%. (based on the last measured and documented laboratory measurement within 6 months)
• High risk for CV events -Established cardiovascular disease and/or multiple risk factors

You may not qualify if…

• Current or previous (within 6 months) treatment with DPP4 inhibitors and/or GLP-1 mimetics
• Acute vascular event <2months prior to randomisation

Where it is running

• Research Site — Phoenix, Arizona, United States
• Research Site — Tempe, Arizona, United States
• Research Site — Tucson, Arizona, United States
• Research Site — Little Rock, Arkansas, United States
• Research Site — Alhambra, California, United States
• Research Site — Anaheim, California, United States
• Research Site — Bakersfield, California, United States
• Research Site — Burlingame, California, United States
• Research Site — Duarte, California, United States
• Research Site — Huntington Park, California, United States
• Research Site — La Mesa, California, United States
• Research Site — Lomita, California, United States
• Research Site — Los Angeles, California, United States
• Research Site — Oceanside, California, United States
• Research Site — Sacramento, California, United States
• Research Site — San Diego, California, United States
• Research Site — San Ramon, California, United States
• Research Site — Torrance, California, United States
• Research Site — Ventura, California, United States
• Research Site — Colorado Springs, Colorado, United States
• Research Site — Denver, Colorado, United States
• Research Site — Longmont, Colorado, United States
• Research Site — Bridgeport, Connecticut, United States
• Research Site — Bristol, Connecticut, United States
• Research Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.